| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
NP Medical Inc is a Clinton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cure International is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lemoyne, PA. To find more information about Cure International, please visit www.cureinternational.org
Pharmacy Access Solutions Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
LiteCure is a Newark, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.